Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Droxidopa for Orthostatic Hypotension in Hemodialysis Patients
NCT01612078Phase 3Terminated
- Sponsor
- TSH Biopharm Corporation Limited
- Start
- Jun 2012
- Primary completion
- Feb 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in orthostatic hypotension (OH) comparing Droxidopa with Placebo (2 arms). Primary endpoint: Change in mean change of systolic blood pressure after hemodialysis at 4 weeks. Started Jun 2012; status: terminated.
02
Drugs
droxidopa
03
Conditions
orthostatic hypotension (OH)
Beyond the preview
Go deeper on NCT01612078.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01612078.